TLDR

1. Injective is experiencing significant fundamental growth, including a new ecosystem acceleration program and an ETF filing, signaling increased institutional interest.

2. Community sentiment remains predominantly bullish, with many expecting INJ to reach price targets of $50-$100+ in 2025, despite recent short-term price fluctuations.

3. Technical indicators show short-term bearish momentum, with INJ's price declining by 6.3% over the last 24 hours, alongside negative money flow and low concentration scores.